» Articles » PMID: 31198545

Are Oxyphil Cells Responsible for the Ineffectiveness of Cinacalcet Hydrochloride in Haemodialysis Patients?

Overview
Journal Clin Kidney J
Specialty Nephrology
Date 2019 Jun 15
PMID 31198545
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Parathyroid glands consist primarily of chief cells. In some cases, the proportion of parathyroid oxyphil cells increases in patients with chronic kidney disease. We describe a case of secondary hyperparathyroidism (SHPT) in a patient treated with haemodialysis who initially received large doses of vitamin D and calcium (Ca) supplements, as well as high doses of cinacalcet hydrochloride (C-HCl), but without any effect on parathyroid hormone levels. Following a successful parathyroidectomy, histopathological examination revealed that two of the parathyroid glands consisted of 40% of oxyphil cells. Oxyphil cells have significantly more Ca-sensing receptors (CaSRs) than chief cells, suggesting that CaSRs are involved in the transdifferentiation of chief cells to oxyphil cells. C-HCl treatment leads to a significant increase in parathyroid oxyphil cell content. This case suggests that C-HCl may induce specific phenotypic alterations in hyperplastic parathyroid glands in patients with severe SHPT.

Citing Articles

Integrated transcriptomic and proteomic analyses for the characterization of parathyroid oxyphil cells in uremic patients.

Mao J, You H, Wang M, Ni L, Zhang Q, Zhang M Amino Acids. 2022; 54(5):749-763.

PMID: 35348903 DOI: 10.1007/s00726-022-03126-8.


Relationship between parathyroid oxyphil cell proportion and clinical characteristics of patients with chronic kidney disease.

Ding Y, Zou Q, Jin Y, Zhou J, Wang H Int Urol Nephrol. 2019; 52(1):155-159.

PMID: 31686279 DOI: 10.1007/s11255-019-02330-y.

References
1.
Chertow G, Plone M, Dillon M, Burke S, Slatopolsky E . Hyperparathyroidism and dialysis vintage. Clin Nephrol. 2000; 54(4):295-300. View

2.
Urena P, Frazao J . Calcimimetic agents: review and perspectives. Kidney Int Suppl. 2003; (85):S91-6. DOI: 10.1046/j.1523-1755.63.s85.22.x. View

3.
Wada M, Nagano N . Control of parathyroid cell growth by calcimimetics. Nephrol Dial Transplant. 2003; 18 Suppl 3:iii13-7. DOI: 10.1093/ndt/gfg1004. View

4.
. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42(4 Suppl 3):S1-201. View

5.
Mizobuchi M, Ogata H, Hatamura I, Saji F, Koiwa F, Kinugasa E . Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells. Biochem Biophys Res Commun. 2007; 362(1):11-16. DOI: 10.1016/j.bbrc.2007.07.177. View